Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or a
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm
05:07am, Monday, 22'nd Sep 2025
LOS ANGELES , Sept. 22, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Novo Nordisk A/S ("Novo Nordisk"
Here Are 2 Defensive Positions That Are Worth A Look Now
10:35pm, Sunday, 21'st Sep 2025
The market will likely pull back at some point, and I think it is smart to start considering some more defensive value positions in your portfolio. NVO remains one of the leaders in the diabetes and o
NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
Ozempic's Maker Got Crushed. The Rebound Is Under Way.
07:00am, Sunday, 21'st Sep 2025
With a weight-loss pill on the horizon and the FDA's signal of a tougher stance on compounded knockoffs, Novo Nordisk might be turning a corner.
NEW YORK, Sept. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025 and July 28,
Is Novo Nordisk Stock a Buy Now?
06:34am, Saturday, 20'th Sep 2025
Two years ago, Novo Nordisk (NVO -0.66%), a Denmark-based pharmaceutical company, was performing so well that it was positively affecting the economy of its home country. However, the past 18 months h
Cost will be key for Novo Nordisk's Wegovy pill, says Dr. Patel
06:16pm, Friday, 19'th Sep 2025
CNBC's “Fast Money” team discusses new obesity drug data and the market leaders, including Novo Nordisk and Eli Lilly, with Dr. Kavita Patel, NBC News and MSNBC medical contributor.
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") (NYSE: NVO) of a class action securities lawsuit.
LOS ANGELES, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 30, 2025 deadline to file a lead plaintiff motion in the class action filed on b
Novo Nordisk: Don't Be Deterred By Outlook Downgrades
12:37pm, Friday, 19'th Sep 2025
Novo Nordisk A/S's repeated downgrades in outlook might spook investors, but here I argue that there's still much to like about it. Stemming from a restructuring plan, if the latest outlook reduction
Can Novo Nordisk Hold Its Edge as the GLP-1 Battle With LLY Heats Up?
11:55am, Friday, 19'th Sep 2025
NVO gains ground in the GLP-1 battle as Ozempic outshines Trulicity in heart risk reduction and Rybelsus wins EU approval for added benefits.
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
10:41am, Friday, 19'th Sep 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Novo To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Novo (NVO) To Contact Him Directly To Discuss Their Options If you purchased or acquired s
3 Stocks Insiders Are Buying Non-Stop
10:00am, Friday, 19'th Sep 2025
Insider buying is one of the few market signals that does not hide behind algorithms or price targets.
